Marin Endocrine Care & Research, Inc.

Greenbrae, California 94904

0 studies enrolling now · 9 studies all time

What they study most

Age Related Osteoporosis, Cardiovascular Disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Kidney Disease, Dupuytren's Disease, High Cardiovascular Risk, Obesity, Osteoporosis, Osteoporosis Localized to Spine, Osteoporosis Senile, Osteoporosis of Vertebrae

Studies at this site

• Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) — Completed
• Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis — Completed
• Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease — Completed
• Mylan Insulin Aspart Study — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules — Completed
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed